Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits QuantWave Forecast Target with 28.23% Profit

November 30, 2022
ELI LILLY AND COMPANY stock recently reached the price target forecasted by QuantWave on April 29, 2022. The forecast signal indicated a long position with a price of $283.64. On November 30, 2022, the stock hit the target price of $363.7, resulting in a profit of 28.23%.

This achievement showcases the accuracy and effectiveness of QuantWave's forecasting analytics. The success of this forecast can be attributed to various factors, including positive developments in the pharmaceutical industry, strong financial performance by ELI LILLY AND COMPANY, and overall market trends.

QuantWave's automated forecasting platform provides users with valuable insights and predictions for a wide range of stocks, offering opportunities for potential profits. For those interested in delving deeper into investment strategies, QuantSchool provides comprehensive educational resources on utilizing the QuantWave forecasting system to generate consistent income.

Find out how the ELI LILLY AND COMPANY rate is expected to change

Get Forecast for LLY
There are no comments yet. Be the first to leave a comment
If you want to leave a comment, then you need Login or Register





Other news for LLY

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....



Related news

REGNAugust 15, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 19.37% Profit: QuantWave Analysis  ~1 min.

REGENERON PHARMACEUTICALS, INC. has achieved the price target forecast set by QuantWave, resulting in a profit of 19.37%....

REGNAugust 15, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 18.25% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved to be highly accurate, as the stock reached the predicted target price of 1172.09 $ on August 15, 2024, from the signal price of 991....

VRTXDecember 19, 2024VERTEX PHARMACEUTICALS INCORPORATED Hits Price Target Forecast with 13.57% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully achieved the price target forecast set by QuantWave, with a profit of 13.57%. The forecast signal was given on October 8th, 2024, with a price of $458....

VRTXMarch 17, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits Forecast Price Target with a Profit of 9.49%  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully reached the forecast price target set by QuantWave on December 17, 2024. The forecast signal indicated a "long" direction with a price of $469....

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.89% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved accurate as the stock reached the predicted target price on April 4, 2025....